CDMO - March 17, 2025
Anocca to start first in-human trial in advanced pancreatic cancer
The company has announced the authorization of its Clinical Trial Application (CTA) from the regulatory authorities in four European countries under the European Union’s (EU) harmonised framework, for VIDAR-1, with Germany acting as the reference state.
CDMO - February 4, 2025
3PBIOVIAN to collaborate with Eleva
The two companies have announced a strategic alliance to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva's technology platform.
Biotech Business - January 15, 2025
NOK 50 million to new Norwegian ATMP infrastructure
The Research Council of Norway has granted NOK 50 million to the Oslo University Hospital (OUH), in partnership with the University of Oslo and the Haukeland University Hospital (HUH) for the development and distribution of ATMPs, reports Sofia Lindén/Oslo Cancer Cluster (OCC).
CDMO - January 14, 2025
ReciBioPharm secures grant to advance RNA manufacturing
ReciBioPharm, a division of Recipharm, has been awarded a three-year grant from the Bill & Melinda Gates Foundation.
CDMO - January 8, 2025
Polypeptide doubles its production capacity in Malmö
PolyPeptide Group has announces the planned doubling of solid-phase peptide synthesis (SPPS) capacity at its manufacturing site in Malmö, Sweden.
Business article - November 4, 2024
Hey there, Helena Strigård
You are arranging a Nordic tour, beginning at BIO-Europe in Stockholm on November 4-6, for different actors within life science manufacturing to showcase our region’s strengths within the field.
